After Aphria Deal, the New Tilray Eyes Global Cannabis Brands

May 3, 2021, 3:41 PM

Tilray Inc. shareholders approved the merger with Aphria Inc., creating a cannabis powerhouse that’s both the largest medical marijuana company in Europe and a major player in Canada’s recreational market.

The company’s ambitions don’t end there, though.

Irwin Simon, the former head of Aphria who is now chairman and chief executive officer of the combined company, has ambitions to transform it from an edgy Canadian marijuana company into a global consumer products giant, potentially selling cannabis in everything from drinks to skin creams to snack bars.

Irwin Simon
Source: Wye Communications

The company, which completed the deal on Monday, will have a ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.